Boston Scientific (BSX) Net Cash Flow Growth (5y) (2014 - 2026)

Boston Scientific (BSX) Net Cash Flow Growth (5y) (2014 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 181.33 Bn 174.04 Bn 6.27 Bn
2 Stryker 128.11 Bn 125.23 Bn 3.81 Bn
3 Medtronic 107.76 Bn 98.54 Bn 6.41 Bn
4 Boston Scientific 67.95 Bn 66.50 Bn 3.61 Bn
5 Edwards Lifesciences 47.64 Bn 43.97 Bn 1.29 Bn
6 GE HealthCare Technologies 28.43 Bn 26.14 Bn 1.98 Bn
7 Dexcom 28.31 Bn 27.20 Bn 750.30 Mn
8 Smith & Nephew 26.77 Bn 26.19 Bn -
9 Koninklijke Philips 25.33 Bn 22.21 Bn 2.07 Bn
10 Steris 21.41 Bn 20.97 Bn 697.10 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -31.52%
Dec 31, 2025 33.75%
Sep 30, 2025 22.70%
Jun 30, 2025 -16.40%
Mar 31, 2025 21.61%
Dec 31, 2024 -90.53%
Sep 30, 2024 27.90%
Jun 30, 2024 58.05%
Mar 31, 2024 -6.87%
Dec 31, 2023 11.71%
Sep 30, 2023 121.82%
Jun 30, 2023 3.72%
Mar 31, 2023 -34.61%
Dec 31, 2022 13.83%
Sep 30, 2022 -26.26%
Jun 30, 2022 -19.53%
Mar 31, 2022 -58.84%
Dec 31, 2021 -44.57%
Sep 30, 2021 -29.51%
Jun 30, 2021 44.61%